OXBRYTA Full Patient Information

(voxelotor)

Full Patient Information

17 PATIENT COUNSELING INFORMATION

Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use).

Hypersensitivity Reactions

Advise patients that serious hypersensitivity reactions including DRESS may occur, and to notify their healthcare providers if they develop generalized rash, urticaria, shortness of breath, facial swelling, swelling around their eyes, lips, or tongue, fever, fatigue, muscle and/or joint pain, swollen glands, and eosinophilia [see Warnings and Precautions (5.1)]. Inform patients that some severe hypersensitivity reactions may affect their internal organs (such as liver, kidneys, lungs) and their blood cells. Advise patients to stop OXBRYTA if a severe hypersensitivity reaction is suspected.

Breastfeeding

Advise women not to breastfeed while they are on OXBRYTA therapy [see Use in Specific Populations (8.2)].

Dosage and Administration

To avoid a dosing error from using the wrong formulation of OXBRYTA, strongly advise patients and caregivers to visually inspect the tablets to verify the correct formulation each time the prescription is filled [see Dosage and Administration (2) and How Supplied/Storage and Handling (16)].

Advise patients to:

•: Store OXBRYTA at 20°C to 30°C (68°F to 86°F).
•: Continue taking OXBRYTA every day for as long as their physician tells them.
•: Do not take St John's wort while taking OXBRYTA.
•: Swallow OXBRYTA tablets whole. Do not cut, crush, or chew the tablets.
•: Do not swallow whole, cut, crush, or chew OXBRYTA tablets for oral suspension. Disperse OXBRYTA tablets for oral suspension in room temperature clear drink (such as drinking water, clear soda, apple juice, clear electrolyte drinks, clear flavored drinks, or clear sports drinks) before administration. The amount of liquid needed to disperse the tablets for oral suspension will depend on the dose (number of tablets prescribed) [see Dosage and Administration (2.7)].
•: Take OXBRYTA with or without food.
•: If a dose is missed or not consumed entirely, resume dosing the following day [see Dosage and Administration (2.7)].

This Patient Information has been approved by the U.S. Food and Drug Administration				Revised: 08/2023
PATIENT INFORMATION
	OXBRYTA (ox brye ta) (voxelotor) tablets			OXBRYTA (ox brye ta) (voxelotor) tablets for oral suspension
What is OXBRYTA? OXBRYTA is a prescription medicine used for the treatment of sickle cell disease in adults and children 4 years of age and older. It is not known if OXBRYTA is safe and effective in children with sickle cell disease below 4 years of age.
Do not take OXBRYTA if you or your child have had an allergic reaction to voxelotor or any of the ingredients in OXBRYTA. See the end of this leaflet for a list of the ingredients in OXBRYTA.
Before taking OXBRYTA, tell your healthcare provider about all of your medical conditions, including if you or your child: • have liver problems • are pregnant or plan to become pregnant. It is not known if OXBRYTA can harm your unborn baby. • are breastfeeding or plan to breastfeed. It is not known if OXBRYTA can pass into your breastmilk and if it can harm your baby. Do not breastfeed during treatment with OXBRYTA and for at least 2 weeks after the last dose. Tell your healthcare provider about all the medicines you or your child take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Some medicines may affect how OXBRYTA works. OXBRYTA may also affect how other medicines work and may affect the results of certain blood tests. Keep a list of all your medicines and show it to your healthcare provider.
How should I take OXBRYTA? • Take OXBRYTA exactly as your healthcare provider tells you. • Do not change your dose or stop taking OXBRYTA unless your healthcare provider tells you to. Your healthcare provider may change your dose if needed. • Take your prescribed dose of OXBRYTA 1 time each day. • Take OXBRYTA with or without food. • OXBRYTA comes in two different dosage forms, OXBRYTA tablets and OXBRYTA tablets for oral suspension. Your healthcare provider will decide which dosage form you take based on your age, weight, and ability to swallow tablets. o If you take OXBRYTA tablets: Swallow each OXBRYTA tablet whole. Do not cut, crush, or chew the tablets. o If you take OXBRYTA tablets for oral suspension: See the detailed Instructions for Use on how to prepare and take your dose. You must mix the OXBRYTA tablets for oral suspension in room temperature clear drink, such as drinking water, clear soda, apple juice, clear electrolyte drinks, clear flavored drinks, or clear sports drinks, right before taking it. Do not swallow whole, cut, crush, or chew the tablets for oral suspension. • Check to make sure you receive the correct dosage form of OXBRYTA each time your prescription is filled to avoid taking the wrong medicine. • Your healthcare provider may also prescribe a medicine called hydroxyurea during treatment with OXBRYTA. • If you or your child miss a dose of OXBRYTA or if the entire dose is not taken, skip that dose and return to your normal dosing schedule the next day.
What should I avoid while taking OXBRYTA? Do not take St. John's wort during treatment with OXBRYTA.
What are the possible side effects of OXBRYTA? OXBRYTA can cause serious side effects, including: • Severe skin rash and serious allergic reactions. Treatment with OXBRYTA may cause severe skin reactions and serious allergic reactions. The organs in your body may also be affected, such as your liver, kidneys or lungs, and your blood cells. • Stop taking OXBRYTA, and tell your healthcare provider or get emergency medical help right away if you develop any of the following signs or symptoms during treatment:
	o rash o hives o high temperature (fever) o swollen glands (lymph nodes) o trouble swallowing		o shortness of breath (difficult breathing) o swelling of your face, around your eyes, lips, or tongue o lack of energy and tiredness (fatigue) o muscle or joint aches
The most common side effects of OXBRYTA include:
• headache • diarrhea • stomach-area (abdominal) pain		• nausea • rash or hives • fever
The most common side effects of OXBRYTA in children ages 4 to less than 12 years of age include:
• fever • vomiting • rash		• stomach-area (abdominal) pain • diarrhea • headache
These are not all the possible side effects of OXBRYTA. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Pfizer Inc. at 1-800-438-1985.
How should I store OXBRYTA? • Store OXBRYTA between 68°F to 86°F (20°C to 30°C). • The OXBRYTA bottle comes with a child-resistant closure. • The OXBRYTA bottle may contain a desiccant canister to help keep your medicine dry (protect it from moisture) and a polyester coil. Do not eat the desiccant or polyester coil. Keep OXBRYTA and all medicines out of the reach of children.
General information about the safe and effective use of OXBRYTA. Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use OXBRYTA for a condition for which it was not prescribed. Do not give OXBRYTA to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about OXBRYTA that is written for health professionals.
What are the ingredients of OXBRYTA? Active Ingredient: voxelotor Inactive Ingredients: OXBRYTA tablets: colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, and sodium lauryl sulfate. The 500 mg tablet film coating contains: polyethylene glycol 3350, polyvinyl alcohol, talc, titanium dioxide, and yellow iron oxide. The 300 mg tablet film coating contains: black and red iron oxide, polyethylene glycol 3350, polyvinyl alcohol, talc, and titanium dioxide. OXBRYTA tablets for oral suspension: artificial grape flavor, colloidal silicon dioxide, croscarmellose sodium, iron oxide pigment, magnesium stearate, microcrystalline cellulose, and sucralose. Distributed by Global Blood Therapeutics, Inc A subsidiary of Pfizer Inc. South San Francisco, CA 94080 LAB-1567-1.0 For more information, go to www.pfizer.com or call 1-800-438-1985.

This Instructions for Use has been approved by the U.S. Food and Drug Administration.			Revised: 08/2023
INSTRUCTIONS FOR USE OXBRYTA [ox brye ta] (voxelotor) tablets for oral suspension 300 mg
This Instructions for Use contains information on how to take OXBRYTA tablets for oral suspension. Read this Instructions for Use before you or your child start taking OXBRYTA tablets for oral suspension for the first time and each time you or your child get a refill. There may be new information. This information does not take the place of talking to your healthcare provider about your or your child's medical condition or treatment. Talk to your healthcare provider or pharmacist if you have questions about how to take or give the prescribed dose of OXBRYTA tablets for oral suspension.
Important Information You Need to Know Before Taking OXBRYTA Tablets for Oral Suspension: • Take OXBRYTA tablets for oral suspension exactly as your healthcare provider tells you. • Your healthcare provider will tell you how many OXBRYTA tablets for oral suspension you will need for your or your child's dose. • OXBRYTA comes in two different dosage forms. Each time you receive your or your child's prescription, check the bottle to make sure that you received the prescribed dosage form of OXBRYTA tablets for oral suspension. OXBRYTA tablets for oral suspension are light yellow to yellow, round shaped, and marked with "300 D" on one side. Contact your pharmacist or healthcare provider if you did not receive the correct dosage form. • Do not swallow whole, cut, crush, or chew OXBRYTA tablets for oral suspension. • You must first mix OXBRYTA tablets for oral suspension in room temperature clear drink, such as drinking water, clear soda, apple juice, clear electrolyte drinks, clear flavored drinks, or clear sports drinks, before swallowing. • If you or your child miss a dose of OXBRYTA tablets for oral suspension or if the entire dose is not taken, skip that dose and return to the normal dosing schedule the next day. • For more information about OXBRYTA tablets for oral suspension, see the Patient Information leaflet.
Gather supplies
You will need the following items to prepare the dose of OXBRYTA tablets for oral suspension (not included with OXBRYTA tablets for oral suspension): • a teaspoon • a small cup • room temperature clear drink, such as drinking water, clear soda, apple juice, clear electrolyte drinks, clear flavored drinks, or clear sports drinks. You will also need: • the prescribed number of OXBRYTA tablets for oral suspension needed for your dose.
Preparing a dose of OXBRYTA tablets for oral suspension
Step 1.	Wash and dry your hands well before preparing the dose.
Step 2.	Pour room temperature clear drink into the cup. The table below shows the amount of clear drink needed for your prescribed dose. You may add more clear drink if needed to mix the tablets.
	Number of OXBRYTA Tablets for Oral Suspension	Amount of Clear Drink
	1	1 teaspoon (5 mL)
	2	2 teaspoons (10 mL)
	3	3 teaspoons (15 mL)
	4	4 teaspoons (20 mL)
	5	5 teaspoons (25 mL)
	7	7 teaspoons (35 mL)
	8	8 teaspoons (40 mL)

Step 3.	Add the prescribed number of OXBRYTA tablets for oral suspension into the cup.
Step 4.	Swirl the cup until the tablet(s) break apart (disperse) in the drink. Be careful not to spill the mixture. • The tablet(s) will not completely dissolve. You will still see small tablet clumps in the mixture. • If you spill any medicine, clean up the spill. Throw away the rest of the prepared medicine and make a new dose.
Step 5.	Wait for 1 to 5 minutes.
Giving the dose
Step 6.	Swirl the cup again. Take or give all of the prepared medicine right away. • If giving to a child, make sure that your child is upright when drinking the medicine mixture.
Step 7.	Add 1 or 2 teaspoons of room temperature clear drink to the cup to make sure the full dose is taken. Swirl the cup until the remaining medicine is mixed and take or give it right away. • Repeat this step until no more medicine is left in the cup. • After all the medicine is taken, you or your child may drink more water or any type of drink.
Step 8.	Wash the teaspoon and cup with warm soap and water.
Storing OXBRYTA • Store OXBRYTA between 68°F to 86°F (20°C to 30°C). • The OXBRYTA bottle comes with a child-resistant closure. • The OXBRYTA tablets for oral suspension bottle contains a polyester coil. Do not eat the polyester coil. Keep OXBRYTA and all medicines out of the reach of children.
Disposing of OXBRYTA When all the tablets in the bottle have been taken, throw away the bottle. Safely dispose of (throw away) OXBRYTA that is out of date or no longer needed using your local household waste guidelines. Distributed by Global Blood Therapeutics, Inc A subsidiary of Pfizer Inc. South San Francisco, CA 94080 LAB-1568-1.0 For more information, go to www.pfizer.com or call 1-800-438-1985.

Find OXBRYTA medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

OXBRYTA Quick Finder

Medication Guide

Health Professional Information

Full Patient Information

17 PATIENT COUNSELING INFORMATION

Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use).

Hypersensitivity Reactions

Breastfeeding

Advise women not to breastfeed while they are on OXBRYTA therapy [see Use in Specific Populations (8.2)].

Dosage and Administration

Advise patients to:

•: Store OXBRYTA at 20°C to 30°C (68°F to 86°F).
•: Continue taking OXBRYTA every day for as long as their physician tells them.
•: Do not take St John's wort while taking OXBRYTA.
•: Swallow OXBRYTA tablets whole. Do not cut, crush, or chew the tablets.
•: Do not swallow whole, cut, crush, or chew OXBRYTA tablets for oral suspension. Disperse OXBRYTA tablets for oral suspension in room temperature clear drink (such as drinking water, clear soda, apple juice, clear electrolyte drinks, clear flavored drinks, or clear sports drinks) before administration. The amount of liquid needed to disperse the tablets for oral suspension will depend on the dose (number of tablets prescribed) [see Dosage and Administration (2.7)].
•: Take OXBRYTA with or without food.
•: If a dose is missed or not consumed entirely, resume dosing the following day [see Dosage and Administration (2.7)].

This Patient Information has been approved by the U.S. Food and Drug Administration				Revised: 08/2023
PATIENT INFORMATION
	OXBRYTA (ox brye ta) (voxelotor) tablets			OXBRYTA (ox brye ta) (voxelotor) tablets for oral suspension
What is OXBRYTA? OXBRYTA is a prescription medicine used for the treatment of sickle cell disease in adults and children 4 years of age and older. It is not known if OXBRYTA is safe and effective in children with sickle cell disease below 4 years of age.
Do not take OXBRYTA if you or your child have had an allergic reaction to voxelotor or any of the ingredients in OXBRYTA. See the end of this leaflet for a list of the ingredients in OXBRYTA.
Before taking OXBRYTA, tell your healthcare provider about all of your medical conditions, including if you or your child: • have liver problems • are pregnant or plan to become pregnant. It is not known if OXBRYTA can harm your unborn baby. • are breastfeeding or plan to breastfeed. It is not known if OXBRYTA can pass into your breastmilk and if it can harm your baby. Do not breastfeed during treatment with OXBRYTA and for at least 2 weeks after the last dose. Tell your healthcare provider about all the medicines you or your child take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Some medicines may affect how OXBRYTA works. OXBRYTA may also affect how other medicines work and may affect the results of certain blood tests. Keep a list of all your medicines and show it to your healthcare provider.
How should I take OXBRYTA? • Take OXBRYTA exactly as your healthcare provider tells you. • Do not change your dose or stop taking OXBRYTA unless your healthcare provider tells you to. Your healthcare provider may change your dose if needed. • Take your prescribed dose of OXBRYTA 1 time each day. • Take OXBRYTA with or without food. • OXBRYTA comes in two different dosage forms, OXBRYTA tablets and OXBRYTA tablets for oral suspension. Your healthcare provider will decide which dosage form you take based on your age, weight, and ability to swallow tablets. o If you take OXBRYTA tablets: Swallow each OXBRYTA tablet whole. Do not cut, crush, or chew the tablets. o If you take OXBRYTA tablets for oral suspension: See the detailed Instructions for Use on how to prepare and take your dose. You must mix the OXBRYTA tablets for oral suspension in room temperature clear drink, such as drinking water, clear soda, apple juice, clear electrolyte drinks, clear flavored drinks, or clear sports drinks, right before taking it. Do not swallow whole, cut, crush, or chew the tablets for oral suspension. • Check to make sure you receive the correct dosage form of OXBRYTA each time your prescription is filled to avoid taking the wrong medicine. • Your healthcare provider may also prescribe a medicine called hydroxyurea during treatment with OXBRYTA. • If you or your child miss a dose of OXBRYTA or if the entire dose is not taken, skip that dose and return to your normal dosing schedule the next day.
What should I avoid while taking OXBRYTA? Do not take St. John's wort during treatment with OXBRYTA.
What are the possible side effects of OXBRYTA? OXBRYTA can cause serious side effects, including: • Severe skin rash and serious allergic reactions. Treatment with OXBRYTA may cause severe skin reactions and serious allergic reactions. The organs in your body may also be affected, such as your liver, kidneys or lungs, and your blood cells. • Stop taking OXBRYTA, and tell your healthcare provider or get emergency medical help right away if you develop any of the following signs or symptoms during treatment:
	o rash o hives o high temperature (fever) o swollen glands (lymph nodes) o trouble swallowing		o shortness of breath (difficult breathing) o swelling of your face, around your eyes, lips, or tongue o lack of energy and tiredness (fatigue) o muscle or joint aches
The most common side effects of OXBRYTA include:
• headache • diarrhea • stomach-area (abdominal) pain		• nausea • rash or hives • fever
The most common side effects of OXBRYTA in children ages 4 to less than 12 years of age include:
• fever • vomiting • rash		• stomach-area (abdominal) pain • diarrhea • headache
These are not all the possible side effects of OXBRYTA. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Pfizer Inc. at 1-800-438-1985.
How should I store OXBRYTA? • Store OXBRYTA between 68°F to 86°F (20°C to 30°C). • The OXBRYTA bottle comes with a child-resistant closure. • The OXBRYTA bottle may contain a desiccant canister to help keep your medicine dry (protect it from moisture) and a polyester coil. Do not eat the desiccant or polyester coil. Keep OXBRYTA and all medicines out of the reach of children.
General information about the safe and effective use of OXBRYTA. Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use OXBRYTA for a condition for which it was not prescribed. Do not give OXBRYTA to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about OXBRYTA that is written for health professionals.
What are the ingredients of OXBRYTA? Active Ingredient: voxelotor Inactive Ingredients: OXBRYTA tablets: colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, and sodium lauryl sulfate. The 500 mg tablet film coating contains: polyethylene glycol 3350, polyvinyl alcohol, talc, titanium dioxide, and yellow iron oxide. The 300 mg tablet film coating contains: black and red iron oxide, polyethylene glycol 3350, polyvinyl alcohol, talc, and titanium dioxide. OXBRYTA tablets for oral suspension: artificial grape flavor, colloidal silicon dioxide, croscarmellose sodium, iron oxide pigment, magnesium stearate, microcrystalline cellulose, and sucralose. Distributed by Global Blood Therapeutics, Inc A subsidiary of Pfizer Inc. South San Francisco, CA 94080 LAB-1567-1.0 For more information, go to www.pfizer.com or call 1-800-438-1985.

This Instructions for Use has been approved by the U.S. Food and Drug Administration.			Revised: 08/2023
INSTRUCTIONS FOR USE OXBRYTA [ox brye ta] (voxelotor) tablets for oral suspension 300 mg
This Instructions for Use contains information on how to take OXBRYTA tablets for oral suspension. Read this Instructions for Use before you or your child start taking OXBRYTA tablets for oral suspension for the first time and each time you or your child get a refill. There may be new information. This information does not take the place of talking to your healthcare provider about your or your child's medical condition or treatment. Talk to your healthcare provider or pharmacist if you have questions about how to take or give the prescribed dose of OXBRYTA tablets for oral suspension.
Important Information You Need to Know Before Taking OXBRYTA Tablets for Oral Suspension: • Take OXBRYTA tablets for oral suspension exactly as your healthcare provider tells you. • Your healthcare provider will tell you how many OXBRYTA tablets for oral suspension you will need for your or your child's dose. • OXBRYTA comes in two different dosage forms. Each time you receive your or your child's prescription, check the bottle to make sure that you received the prescribed dosage form of OXBRYTA tablets for oral suspension. OXBRYTA tablets for oral suspension are light yellow to yellow, round shaped, and marked with "300 D" on one side. Contact your pharmacist or healthcare provider if you did not receive the correct dosage form. • Do not swallow whole, cut, crush, or chew OXBRYTA tablets for oral suspension. • You must first mix OXBRYTA tablets for oral suspension in room temperature clear drink, such as drinking water, clear soda, apple juice, clear electrolyte drinks, clear flavored drinks, or clear sports drinks, before swallowing. • If you or your child miss a dose of OXBRYTA tablets for oral suspension or if the entire dose is not taken, skip that dose and return to the normal dosing schedule the next day. • For more information about OXBRYTA tablets for oral suspension, see the Patient Information leaflet.
Gather supplies
You will need the following items to prepare the dose of OXBRYTA tablets for oral suspension (not included with OXBRYTA tablets for oral suspension): • a teaspoon • a small cup • room temperature clear drink, such as drinking water, clear soda, apple juice, clear electrolyte drinks, clear flavored drinks, or clear sports drinks. You will also need: • the prescribed number of OXBRYTA tablets for oral suspension needed for your dose.
Preparing a dose of OXBRYTA tablets for oral suspension
Step 1.	Wash and dry your hands well before preparing the dose.
Step 2.	Pour room temperature clear drink into the cup. The table below shows the amount of clear drink needed for your prescribed dose. You may add more clear drink if needed to mix the tablets.
	Number of OXBRYTA Tablets for Oral Suspension	Amount of Clear Drink
	1	1 teaspoon (5 mL)
	2	2 teaspoons (10 mL)
	3	3 teaspoons (15 mL)
	4	4 teaspoons (20 mL)
	5	5 teaspoons (25 mL)
	7	7 teaspoons (35 mL)
	8	8 teaspoons (40 mL)

Step 3.	Add the prescribed number of OXBRYTA tablets for oral suspension into the cup.
Step 4.	Swirl the cup until the tablet(s) break apart (disperse) in the drink. Be careful not to spill the mixture. • The tablet(s) will not completely dissolve. You will still see small tablet clumps in the mixture. • If you spill any medicine, clean up the spill. Throw away the rest of the prepared medicine and make a new dose.
Step 5.	Wait for 1 to 5 minutes.
Giving the dose
Step 6.	Swirl the cup again. Take or give all of the prepared medicine right away. • If giving to a child, make sure that your child is upright when drinking the medicine mixture.
Step 7.	Add 1 or 2 teaspoons of room temperature clear drink to the cup to make sure the full dose is taken. Swirl the cup until the remaining medicine is mixed and take or give it right away. • Repeat this step until no more medicine is left in the cup. • After all the medicine is taken, you or your child may drink more water or any type of drink.
Step 8.	Wash the teaspoon and cup with warm soap and water.
Storing OXBRYTA • Store OXBRYTA between 68°F to 86°F (20°C to 30°C). • The OXBRYTA bottle comes with a child-resistant closure. • The OXBRYTA tablets for oral suspension bottle contains a polyester coil. Do not eat the polyester coil. Keep OXBRYTA and all medicines out of the reach of children.
Disposing of OXBRYTA When all the tablets in the bottle have been taken, throw away the bottle. Safely dispose of (throw away) OXBRYTA that is out of date or no longer needed using your local household waste guidelines. Distributed by Global Blood Therapeutics, Inc A subsidiary of Pfizer Inc. South San Francisco, CA 94080 LAB-1568-1.0 For more information, go to www.pfizer.com or call 1-800-438-1985.

Prescribing Information

Download Prescribing Information

Health Professional Information

Full Patient Information

17 PATIENT COUNSELING INFORMATION

Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use).

Hypersensitivity Reactions

Breastfeeding

Advise women not to breastfeed while they are on OXBRYTA therapy [see Use in Specific Populations (8.2)].

Dosage and Administration

Advise patients to:

•: Store OXBRYTA at 20°C to 30°C (68°F to 86°F).
•: Continue taking OXBRYTA every day for as long as their physician tells them.
•: Do not take St John's wort while taking OXBRYTA.
•: Swallow OXBRYTA tablets whole. Do not cut, crush, or chew the tablets.
•: Do not swallow whole, cut, crush, or chew OXBRYTA tablets for oral suspension. Disperse OXBRYTA tablets for oral suspension in room temperature clear drink (such as drinking water, clear soda, apple juice, clear electrolyte drinks, clear flavored drinks, or clear sports drinks) before administration. The amount of liquid needed to disperse the tablets for oral suspension will depend on the dose (number of tablets prescribed) [see Dosage and Administration (2.7)].
•: Take OXBRYTA with or without food.
•: If a dose is missed or not consumed entirely, resume dosing the following day [see Dosage and Administration (2.7)].

This Patient Information has been approved by the U.S. Food and Drug Administration				Revised: 08/2023
PATIENT INFORMATION
	OXBRYTA (ox brye ta) (voxelotor) tablets			OXBRYTA (ox brye ta) (voxelotor) tablets for oral suspension
What is OXBRYTA? OXBRYTA is a prescription medicine used for the treatment of sickle cell disease in adults and children 4 years of age and older. It is not known if OXBRYTA is safe and effective in children with sickle cell disease below 4 years of age.
Do not take OXBRYTA if you or your child have had an allergic reaction to voxelotor or any of the ingredients in OXBRYTA. See the end of this leaflet for a list of the ingredients in OXBRYTA.
Before taking OXBRYTA, tell your healthcare provider about all of your medical conditions, including if you or your child: • have liver problems • are pregnant or plan to become pregnant. It is not known if OXBRYTA can harm your unborn baby. • are breastfeeding or plan to breastfeed. It is not known if OXBRYTA can pass into your breastmilk and if it can harm your baby. Do not breastfeed during treatment with OXBRYTA and for at least 2 weeks after the last dose. Tell your healthcare provider about all the medicines you or your child take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Some medicines may affect how OXBRYTA works. OXBRYTA may also affect how other medicines work and may affect the results of certain blood tests. Keep a list of all your medicines and show it to your healthcare provider.
How should I take OXBRYTA? • Take OXBRYTA exactly as your healthcare provider tells you. • Do not change your dose or stop taking OXBRYTA unless your healthcare provider tells you to. Your healthcare provider may change your dose if needed. • Take your prescribed dose of OXBRYTA 1 time each day. • Take OXBRYTA with or without food. • OXBRYTA comes in two different dosage forms, OXBRYTA tablets and OXBRYTA tablets for oral suspension. Your healthcare provider will decide which dosage form you take based on your age, weight, and ability to swallow tablets. o If you take OXBRYTA tablets: Swallow each OXBRYTA tablet whole. Do not cut, crush, or chew the tablets. o If you take OXBRYTA tablets for oral suspension: See the detailed Instructions for Use on how to prepare and take your dose. You must mix the OXBRYTA tablets for oral suspension in room temperature clear drink, such as drinking water, clear soda, apple juice, clear electrolyte drinks, clear flavored drinks, or clear sports drinks, right before taking it. Do not swallow whole, cut, crush, or chew the tablets for oral suspension. • Check to make sure you receive the correct dosage form of OXBRYTA each time your prescription is filled to avoid taking the wrong medicine. • Your healthcare provider may also prescribe a medicine called hydroxyurea during treatment with OXBRYTA. • If you or your child miss a dose of OXBRYTA or if the entire dose is not taken, skip that dose and return to your normal dosing schedule the next day.
What should I avoid while taking OXBRYTA? Do not take St. John's wort during treatment with OXBRYTA.
What are the possible side effects of OXBRYTA? OXBRYTA can cause serious side effects, including: • Severe skin rash and serious allergic reactions. Treatment with OXBRYTA may cause severe skin reactions and serious allergic reactions. The organs in your body may also be affected, such as your liver, kidneys or lungs, and your blood cells. • Stop taking OXBRYTA, and tell your healthcare provider or get emergency medical help right away if you develop any of the following signs or symptoms during treatment:
	o rash o hives o high temperature (fever) o swollen glands (lymph nodes) o trouble swallowing		o shortness of breath (difficult breathing) o swelling of your face, around your eyes, lips, or tongue o lack of energy and tiredness (fatigue) o muscle or joint aches
The most common side effects of OXBRYTA include:
• headache • diarrhea • stomach-area (abdominal) pain		• nausea • rash or hives • fever
The most common side effects of OXBRYTA in children ages 4 to less than 12 years of age include:
• fever • vomiting • rash		• stomach-area (abdominal) pain • diarrhea • headache
These are not all the possible side effects of OXBRYTA. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Pfizer Inc. at 1-800-438-1985.
How should I store OXBRYTA? • Store OXBRYTA between 68°F to 86°F (20°C to 30°C). • The OXBRYTA bottle comes with a child-resistant closure. • The OXBRYTA bottle may contain a desiccant canister to help keep your medicine dry (protect it from moisture) and a polyester coil. Do not eat the desiccant or polyester coil. Keep OXBRYTA and all medicines out of the reach of children.
General information about the safe and effective use of OXBRYTA. Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use OXBRYTA for a condition for which it was not prescribed. Do not give OXBRYTA to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about OXBRYTA that is written for health professionals.
What are the ingredients of OXBRYTA? Active Ingredient: voxelotor Inactive Ingredients: OXBRYTA tablets: colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, and sodium lauryl sulfate. The 500 mg tablet film coating contains: polyethylene glycol 3350, polyvinyl alcohol, talc, titanium dioxide, and yellow iron oxide. The 300 mg tablet film coating contains: black and red iron oxide, polyethylene glycol 3350, polyvinyl alcohol, talc, and titanium dioxide. OXBRYTA tablets for oral suspension: artificial grape flavor, colloidal silicon dioxide, croscarmellose sodium, iron oxide pigment, magnesium stearate, microcrystalline cellulose, and sucralose. Distributed by Global Blood Therapeutics, Inc A subsidiary of Pfizer Inc. South San Francisco, CA 94080 LAB-1567-1.0 For more information, go to www.pfizer.com or call 1-800-438-1985.

This Instructions for Use has been approved by the U.S. Food and Drug Administration.			Revised: 08/2023
INSTRUCTIONS FOR USE OXBRYTA [ox brye ta] (voxelotor) tablets for oral suspension 300 mg
This Instructions for Use contains information on how to take OXBRYTA tablets for oral suspension. Read this Instructions for Use before you or your child start taking OXBRYTA tablets for oral suspension for the first time and each time you or your child get a refill. There may be new information. This information does not take the place of talking to your healthcare provider about your or your child's medical condition or treatment. Talk to your healthcare provider or pharmacist if you have questions about how to take or give the prescribed dose of OXBRYTA tablets for oral suspension.
Important Information You Need to Know Before Taking OXBRYTA Tablets for Oral Suspension: • Take OXBRYTA tablets for oral suspension exactly as your healthcare provider tells you. • Your healthcare provider will tell you how many OXBRYTA tablets for oral suspension you will need for your or your child's dose. • OXBRYTA comes in two different dosage forms. Each time you receive your or your child's prescription, check the bottle to make sure that you received the prescribed dosage form of OXBRYTA tablets for oral suspension. OXBRYTA tablets for oral suspension are light yellow to yellow, round shaped, and marked with "300 D" on one side. Contact your pharmacist or healthcare provider if you did not receive the correct dosage form. • Do not swallow whole, cut, crush, or chew OXBRYTA tablets for oral suspension. • You must first mix OXBRYTA tablets for oral suspension in room temperature clear drink, such as drinking water, clear soda, apple juice, clear electrolyte drinks, clear flavored drinks, or clear sports drinks, before swallowing. • If you or your child miss a dose of OXBRYTA tablets for oral suspension or if the entire dose is not taken, skip that dose and return to the normal dosing schedule the next day. • For more information about OXBRYTA tablets for oral suspension, see the Patient Information leaflet.
Gather supplies
You will need the following items to prepare the dose of OXBRYTA tablets for oral suspension (not included with OXBRYTA tablets for oral suspension): • a teaspoon • a small cup • room temperature clear drink, such as drinking water, clear soda, apple juice, clear electrolyte drinks, clear flavored drinks, or clear sports drinks. You will also need: • the prescribed number of OXBRYTA tablets for oral suspension needed for your dose.
Preparing a dose of OXBRYTA tablets for oral suspension
Step 1.	Wash and dry your hands well before preparing the dose.
Step 2.	Pour room temperature clear drink into the cup. The table below shows the amount of clear drink needed for your prescribed dose. You may add more clear drink if needed to mix the tablets.
	Number of OXBRYTA Tablets for Oral Suspension	Amount of Clear Drink
	1	1 teaspoon (5 mL)
	2	2 teaspoons (10 mL)
	3	3 teaspoons (15 mL)
	4	4 teaspoons (20 mL)
	5	5 teaspoons (25 mL)
	7	7 teaspoons (35 mL)
	8	8 teaspoons (40 mL)

Step 3.	Add the prescribed number of OXBRYTA tablets for oral suspension into the cup.
Step 4.	Swirl the cup until the tablet(s) break apart (disperse) in the drink. Be careful not to spill the mixture. • The tablet(s) will not completely dissolve. You will still see small tablet clumps in the mixture. • If you spill any medicine, clean up the spill. Throw away the rest of the prepared medicine and make a new dose.
Step 5.	Wait for 1 to 5 minutes.
Giving the dose
Step 6.	Swirl the cup again. Take or give all of the prepared medicine right away. • If giving to a child, make sure that your child is upright when drinking the medicine mixture.
Step 7.	Add 1 or 2 teaspoons of room temperature clear drink to the cup to make sure the full dose is taken. Swirl the cup until the remaining medicine is mixed and take or give it right away. • Repeat this step until no more medicine is left in the cup. • After all the medicine is taken, you or your child may drink more water or any type of drink.
Step 8.	Wash the teaspoon and cup with warm soap and water.
Storing OXBRYTA • Store OXBRYTA between 68°F to 86°F (20°C to 30°C). • The OXBRYTA bottle comes with a child-resistant closure. • The OXBRYTA tablets for oral suspension bottle contains a polyester coil. Do not eat the polyester coil. Keep OXBRYTA and all medicines out of the reach of children.
Disposing of OXBRYTA When all the tablets in the bottle have been taken, throw away the bottle. Safely dispose of (throw away) OXBRYTA that is out of date or no longer needed using your local household waste guidelines. Distributed by Global Blood Therapeutics, Inc A subsidiary of Pfizer Inc. South San Francisco, CA 94080 LAB-1568-1.0 For more information, go to www.pfizer.com or call 1-800-438-1985.

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985^*

*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.